Assessing Obesity-Related Adipose Tissue Disease (OrAD) to Improve Precision Medicine for Patients Living With Obesity.
adipocyte
adipose tissue
cell size
fibrosis
inflammation
obesity
precision medicine
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
01
2022
accepted:
15
03
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
Obesity is a heterogenous condition that affects the life and health of patients to different degrees and in different ways. Yet, most approaches to treat obesity are not currently prescribed, at least in a systematic manner, based on individual obesity sub-phenotypes or specifically-predicted health risks. Adipose tissue is one of the most evidently affected tissues in obesity. The degree of adipose tissue changes - "adiposopathy", or as we propose to relate to herein as Obesity-related Adipose tissue Disease (OrAD), correspond, at least cross-sectionally, to the extent of obesity-related complications inflicted on an individual patient. This potentially provides an opportunity to better personalize anti-obesity management by utilizing the information that can be retrieved by assessing OrAD. This review article will summarize current knowledge on histopathological OrAD features which, beyond cross-sectional analyses, had been shown to predict future obesity-related endpoints and/or the response to specific anti-obesity interventions. In particular, the review explores adipocyte cell size, adipose tissue inflammation, and fibrosis. Rather than highly-specialized methods, we emphasize standard pathology laboratory approaches to assess OrAD, which are readily-available in most clinical settings. We then discuss how OrAD assessment can be streamlined in the obesity/weight-management clinic. We propose that current studies provide sufficient evidence to inspire concerted efforts to better explore the possibility of predicting obesity related clinical endpoints and response to interventions by histological OrAD assessment, in the quest to improve precision medicine in obesity.
Identifiants
pubmed: 35574032
doi: 10.3389/fendo.2022.860799
pmc: PMC9098964
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
860799Informations de copyright
Copyright © 2022 Pincu, Yoel, Haim, Makarenkov, Maixner, Shaco-Levy, Bashan, Dicker and Rudich.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Obesity (Silver Spring). 2017 Jan;25(1):15
pubmed: 27935267
Nat Med. 2021 Nov;27(11):1941-1953
pubmed: 34608330
Diabetologia. 2017 Oct;60(10):1892-1902
pubmed: 28733906
Obesity (Silver Spring). 2019 Jun;27(6):957-962
pubmed: 31004409
J Hepatol. 2009 Aug;51(2):354-62
pubmed: 19464069
Diabetes. 2020 Nov;69(11):2310-2323
pubmed: 32732304
Obesity (Silver Spring). 2017 Jan;25(1):122-131
pubmed: 27883275
Circ Res. 2005 May 13;96(9):939-49
pubmed: 15890981
Diabetes. 2016 May;65(5):1245-54
pubmed: 26884438
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):96-102
pubmed: 24291610
J Clin Endocrinol Metab. 2011 Dec;96(12):E2045-9
pubmed: 21994963
Diabetes Care. 2006 Jun;29(6):1337-44
pubmed: 16732018
J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33
pubmed: 17164304
Metabolism. 2014 Dec;63(12):1542-52
pubmed: 25267016
Am J Clin Nutr. 2012 Jan;95(1):49-63
pubmed: 22170375
Nutr Diabetes. 2015 Aug 10;5:e175
pubmed: 26258766
J Clin Endocrinol Metab. 2014 Mar;99(3):898-907
pubmed: 24423338
Nat Rev Endocrinol. 2017 Nov;13(11):633-643
pubmed: 28799554
J Clin Endocrinol Metab. 2010 Jan;95(1):67-73
pubmed: 19890025
Nat Metab. 2020 Jan;2(1):97-109
pubmed: 32066997
Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):81-7
pubmed: 22327367
Curr Opin Endocrinol Diabetes Obes. 2011 Apr;18(2):139-43
pubmed: 21297467
Metabolism. 1971 Jul;20(7):703-13
pubmed: 5090134
Cell Mol Life Sci. 2010 Apr;67(8):1277-92
pubmed: 20107860
Diabetes. 2010 Nov;59(11):2817-25
pubmed: 20713683
Obes Surg. 2015 Aug;25(8):1474-81
pubmed: 25595383
PLoS One. 2007 Dec 19;2(12):e1344
pubmed: 18094752
Obesity (Silver Spring). 2014 Aug;22(8):1807-13
pubmed: 24719315
Diabetes. 2011 May;60(5):1504-11
pubmed: 21421806
Clin Sci (Lond). 2016 Sep 1;130(18):1603-14
pubmed: 27503945
Biomedicines. 2021 Jan 11;9(1):
pubmed: 33440802
Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E506-15
pubmed: 20570822
J Clin Endocrinol Metab. 2007 Jun;92(6):2240-7
pubmed: 17374712
Arch Dis Child. 1973 Apr;48(4):301-4
pubmed: 4705934
Endocr Rev. 2019 Aug 1;40(4):1080-1091
pubmed: 31127805
Front Immunol. 2021 May 21;12:664576
pubmed: 34093556
PLoS One. 2016 Jul 21;11(7):e0159350
pubmed: 27442250
Diabetes. 2005 Aug;54(8):2277-86
pubmed: 16046292
J Clin Endocrinol Metab. 2013 Aug;98(8):E1360-3
pubmed: 23780376
Cell Metab. 2016 Apr 12;23(4):591-601
pubmed: 26916363
Quant Imaging Med Surg. 2021 May;11(5):2162-2168
pubmed: 33936996
Metabolism. 2014 Mar;63(3):372-81
pubmed: 24369916
Obesity (Silver Spring). 2012 May;20(5):932-8
pubmed: 22240722
Adipocyte. 2021 Dec;10(1):558-573
pubmed: 34743657
Obesity (Silver Spring). 2016 Jul;24(7):1438-45
pubmed: 27228052
J Clin Invest. 2003 Dec;112(12):1821-30
pubmed: 14679177
PLoS One. 2014 Aug 22;9(8):e105262
pubmed: 25148116
J Clin Endocrinol Metab. 2009 Dec;94(12):5155-62
pubmed: 19837927
Cell Rep. 2014 May 22;7(4):1116-29
pubmed: 24794440
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3194-3204
pubmed: 29846621
Nutr Metab Cardiovasc Dis. 2019 Jan;29(1):62-68
pubmed: 30497926
Ageing Res Rev. 2021 May;67:101259
pubmed: 33515751
J Clin Endocrinol Metab. 2012 Sep;97(9):E1677-85
pubmed: 22745246
J Clin Endocrinol Metab. 2014 Aug;99(8):E1466-70
pubmed: 24780048
Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C375-C391
pubmed: 33356944
Diabetologia. 2010 Dec;53(12):2496-503
pubmed: 20830466
Circ Res. 2020 May 22;126(11):1477-1500
pubmed: 32437302
Obesity (Silver Spring). 2016 Mar;24(3):597-605
pubmed: 26916240
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2637-43
pubmed: 25341798
Diabetes Care. 2014 Oct;37(10):2789-97
pubmed: 25011943
Diabetologia. 2009 May;52(5):882-90
pubmed: 19252892
Diabetes Care. 2012 Mar;35(3):640-7
pubmed: 22344612
Obesity (Silver Spring). 2013 Jun;21(6):1174-9
pubmed: 23913731
J Clin Endocrinol Metab. 2016 Jan;101(1):293-304
pubmed: 26583585
Mol Nutr Food Res. 2018 Jan;62(2):
pubmed: 29024341
J Clin Invest. 1995 May;95(5):2409-15
pubmed: 7738205
Compr Physiol. 2018 Dec 13;9(1):1-58
pubmed: 30549014
J Clin Invest. 1968 Jan;47(1):153-65
pubmed: 16695937
Obes Surg. 2006 Jun;16(6):804-6
pubmed: 16756747
Diabetes Care. 2014 Jul;37(7):1831-6
pubmed: 24760260
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2443-2453
pubmed: 28419237
Diabetes. 2006 Jun;55(6):1554-61
pubmed: 16731817
Diabetologia. 2000 Dec;43(12):1498-506
pubmed: 11151758
J Clin Endocrinol Metab. 2009 Nov;94(11):4453-7
pubmed: 19820024
Clin Endocrinol Metab. 1976 Jul;5(2):299-311
pubmed: 1085232
Can J Diabetes. 2017 Aug;41(4):407-417
pubmed: 28365202
Am J Clin Nutr. 2009 Jan;89(1):51-7
pubmed: 19056587
Diabetes. 2010 Jan;59(1):105-9
pubmed: 19846802
Circ Heart Fail. 2022 Mar;15(3):e009238
pubmed: 34935412
Cells. 2020 Jun 20;9(6):
pubmed: 32575785
PLoS One. 2012;7(6):e39930
pubmed: 22768174
Int J Obes (Lond). 2015 Jun;39(6):893-8
pubmed: 25666530
J Clin Endocrinol Metab. 2011 Feb;96(2):E304-11
pubmed: 21084397
Metabolism. 2017 May;70:12-22
pubmed: 28403936
Nat Genet. 2017 Jan;49(1):17-26
pubmed: 27841877
Obes Rev. 2014 Apr;15(4):322-37
pubmed: 24251825
J Clin Invest. 1973 Apr;52(4):929-41
pubmed: 4693656
World J Diabetes. 2015 May 15;6(4):548-53
pubmed: 25987952
Crit Rev Clin Lab Sci. 2015;52(6):301-13
pubmed: 26292076
Diabetes. 2012 Sep;61(9):2238-47
pubmed: 22596049
J Clin Invest. 2017 Jan 3;127(1):83-93
pubmed: 28045401
Diabetes Metab. 2017 Apr;43(2):134-139
pubmed: 27639310
Metabolism. 1999 Mar;48(3):355-62
pubmed: 10094113
J Clin Invest. 2012 Dec;122(12):4667-74
pubmed: 23187122
Annu Rev Physiol. 2022 Feb 10;84:135-155
pubmed: 34752708
Am J Physiol Regul Integr Comp Physiol. 2018 Aug 1;315(2):R284-R295
pubmed: 29641234
Genome Biol. 2008 Jan 21;9(1):R14
pubmed: 18208606
Diabetologia. 2007 Mar;50(3):625-33
pubmed: 17216279
Metabolism. 2014 Apr;63(4):492-501
pubmed: 24467914
Am J Clin Nutr. 2010 Oct;92(4):975-84
pubmed: 20739421
Int J Obes Relat Metab Disord. 2003 Oct;27(10):1178-86
pubmed: 14513065
Diabetes. 2009 Mar;58(3):718-25
pubmed: 19074987
Diabetes. 2010 Sep;59(9):2288-96
pubmed: 20805387
J Clin Endocrinol Metab. 2011 Dec;96(12):E1990-8
pubmed: 21994960
Nutr Metab Cardiovasc Dis. 2016 Mar;26(3):246-53
pubmed: 26841679
Sci Rep. 2021 Aug 23;11(1):17050
pubmed: 34426590
J Clin Endocrinol Metab. 2013 Mar;98(3):1173-81
pubmed: 23372170
Int J Obes (Lond). 2013 Jun;37(6):867-73
pubmed: 23399771
Metabolism. 1975 Jun;24(6):703-10
pubmed: 1128235
Obes Res Clin Pract. 2018 Nov - Dec;12(6):570-577
pubmed: 29960868
Sci Transl Med. 2015 Sep 9;7(304):304re7
pubmed: 26355033
FASEB J. 2010 Jan;24(1):326-31
pubmed: 19741173
J Endocrinol Invest. 2007 Mar;30(3):210-4
pubmed: 17505154
J Int Med Res. 2021 May;49(5):3000605211012569
pubmed: 34024182
PLoS One. 2014 Sep 24;9(9):e108421
pubmed: 25251402
Obesity (Silver Spring). 2010 May;18(5):1026-32
pubmed: 19851304
Int J Mol Sci. 2020 Aug 21;21(17):
pubmed: 32825788
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Diabetologia. 2007 Aug;50(8):1707-15
pubmed: 17549449
JAMA Netw Open. 2021 May 3;4(5):e218505
pubmed: 33961036
Diabetes Metab. 2017 Apr;43(2):125-133
pubmed: 27843076
Int J Obes (Lond). 2014 Nov;38(11):1423-31
pubmed: 24549139
Circulation. 2006 Aug 15;114(7):623-9
pubmed: 16894037
Diabetes Care. 2013 Jun;36(6):1547-53
pubmed: 23275369
Surg Obes Relat Dis. 2011 Jan-Feb;7(1):60-7
pubmed: 20678967